Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  World journal of urology

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00345-010-0595-6PMID 20886218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas

  2009cited by this paper
• Progress in the development of matrix metalloproteinase inhibitors.

  2008cited by this paper
• Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells

  2007cited by this paper
• Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

  2007cited by this paper
• [Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer].

  2005cited by this paper
• Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

  2005cited by this paper
• Tissue inhibitor of metalloproteinases-1 in breast cancer.

  2005cited by this paper
• Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

  2005cited by this paper
• Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

  2004cited by this paper
• Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment

  2004cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

  2002cited by this paper
• Complex roles of tissue inhibitors of metalloproteinases in cancer

  2002cited by this paper
• Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.

  2001cited by this paper
• Malignant transformation in a nontumorigenic human prostatic epithelial cell line.

  2001cited by this paper
• Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Demonstration in vivo that stromelysin-3 functions through its proteolytic activity

  2000cited by this paper
• Generation and degradation of human endostatin proteins by various proteinases

  2000cited by this paper
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

  1999cited by this paper
• Matrix metalloproteinases generate angiostatin: effects on neovascularization.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers.

  1998cited by this paper
• Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma.

  1997cited by this paper
• Co‐inoculation of tumorigenic rat prostate mesenchymal cells with non‐tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals

  1989cited by this paper

• Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer

  2023cites this paper
• The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review

  2021cites this paper
• Co‐expression of TLR‐9 and MMP‐13 is associated with the degree of tumour differentiation in prostate cancer

  2019cites this paper
• RNA‐based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP‐2 upregulation for a subsequent prostate cancer diagnosis

  2018cites this paper
• Proteases as prognostic markers in human and canine cancers

  2017cites this paper
• MMPs in Biology and Medicine

  2015cites this paper
• The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions

  2015cites this paper
• Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

  2015cites this paper
• Toll-like Receptor-4 Expression by Stromal Fibroblasts Is Associated With Poor Prognosis in Colorectal Cancer

  2013cites this paper
• Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy

  2013cites this paper
• Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets

  2013cites this paper
• Role of Reactive Stroma in Prostate Cancer

  2013cites this paper
• Molecular markers for progression of squamous cell carcinoma of the skin

  2012cites this paper
• The Stroma—A Key Regulator in Prostate Function and Malignancy

  2012cites this paper